A personalized medicine diagnostics company assessing the activity of mutations and combination of mutations and their response to targeted drugs
Location: United States, Pennsylvania, Philadelphia
Total raised: $75M
Investors 3
| Date | Name | Website |
| - | OrbiMed | orbimed.co... |
| - | HBM Partne... | hbmpartner... |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 25.08.2023 | Series D | $75M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 25.08.2023 | Fore Biotherapeutics Raises $75M in Series D Financing | Fore Biotherapeutics, a Philadelphia, PA-based precision oncology company, raised $75M in Series D f... | finsmes.co... |
| 23.08.2023 | FORE Biotherapeutics raised a $75M Series D and announced an... | Update: Details about funding and employee count from a FORE spokesperson have been added. (8/23/23,... | technical.... |
| 19.05.2021 | Fore Biotherapeutics Strengthens Leadership Team with Execut... | Company appoints biotech industry experts Stacie Peacock Shepherd, M.D., Ph.D., as Chief Medical Off... | 3bfuturehe... |
| 24.02.2021 | NovellusDx Establishes Fore Biotherapeutics U.S. as its Oper... | Company launch and rebrand in the US reflects expert leadership in precision oncology and a new busi... | 3bfuturehe... |